• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

丙磺舒对普鲁卡因胺药代动力学和药效学的影响。

Effect of probenecid on the pharmacokinetics and pharmacodynamics of procainamide.

作者信息

Lam Y W, Boyd R A, Chin S K, Chang D, Giacomini K M

机构信息

Department of Pharmacology, University of Texas Health Science Center, San Antonio 78284-7765.

出版信息

J Clin Pharmacol. 1991 May;31(5):429-32. doi: 10.1002/j.1552-4604.1991.tb01898.x.

DOI:10.1002/j.1552-4604.1991.tb01898.x
PMID:2050827
Abstract

Renal tubular transport of organic anions and cations is assumed to be mutually exclusive. However, results of a number of in vitro and in vivo studies suggest an interaction between the organic anion, probenecid, and various organic cations in the proximal renal tubule. To evaluate the clinical importance of such an interaction, the authors investigated the pharmacokinetics and pharmacodynamics of procainamide, an organic cation with a low therapeutic index that is excreted in part by active secretion in the proximal tubule, in the presence and absence of probenecid. In a randomized crossover study, six healthy subjects received a single 750-mg IV dose of procainamide, with and without prior probenecid administration (2 g orally). Blood and urine samples were obtained and pharmacokinetic parameters of procainamide were determined in each treatment period. QT intervals were measured from ECG recordings that were obtained at blood collection times for pharmacodynamic evaluation. Coadministration of probenecid did not result in any significant change in the overall disposition of procainamide. In particular, renal clearance was not significantly different (488 +/- 95 mL/min without probenecid vs. 478 +/- 69 mL/min in the presence of probenecid). Our data suggest an interaction between probenecid and procainamide in the proximal renal tubule does not exit. Reasons for this lack of interaction are discussed.

摘要

肾小管对有机阴离子和阳离子的转运被认为是相互排斥的。然而,一些体外和体内研究结果表明,有机阴离子丙磺舒与近端肾小管中的各种有机阳离子之间存在相互作用。为了评估这种相互作用的临床重要性,作者研究了在有和没有丙磺舒存在的情况下,普鲁卡因胺(一种治疗指数较低的有机阳离子,部分通过近端小管的主动分泌排泄)的药代动力学和药效学。在一项随机交叉研究中,六名健康受试者接受了单次750毫克静脉注射剂量的普鲁卡因胺,分别在服用和未服用丙磺舒(口服2克)之前。采集血液和尿液样本,并在每个治疗期测定普鲁卡因胺的药代动力学参数。从采血时获得的心电图记录中测量QT间期,用于药效学评估。丙磺舒的共同给药并未导致普鲁卡因胺的总体处置发生任何显著变化。特别是,肾脏清除率没有显著差异(未服用丙磺舒时为488±95毫升/分钟,服用丙磺舒时为478±69毫升/分钟)。我们的数据表明,丙磺舒与近端肾小管中的普鲁卡因胺之间不存在相互作用。讨论了这种缺乏相互作用的原因。

相似文献

1
Effect of probenecid on the pharmacokinetics and pharmacodynamics of procainamide.丙磺舒对普鲁卡因胺药代动力学和药效学的影响。
J Clin Pharmacol. 1991 May;31(5):429-32. doi: 10.1002/j.1552-4604.1991.tb01898.x.
2
Inhibitory effects of procainamide and probenecid on renal excretion of sultopride enantiomers in rats.
J Pharm Sci. 1993 Dec;82(12):1259-61. doi: 10.1002/jps.2600821215.
3
Procainamide uptake by rabbit proximal tubules.
J Pharmacol Exp Ther. 1983 Feb;224(2):302-6.
4
Effects of ofloxacin on the pharmacokinetics and pharmacodynamics of procainamide.氧氟沙星对普鲁卡因胺药代动力学和药效学的影响。 (注:原文中“of ofloxacin”多了一个“of”)
J Clin Pharmacol. 1996 Jan;36(1):85-91. doi: 10.1002/j.1552-4604.1996.tb04156.x.
5
The effect of probenecid on the renal elimination of cimetidine.丙磺舒对西咪替丁肾脏排泄的影响。
Clin Pharmacol Ther. 1989 Apr;45(4):444-52. doi: 10.1038/clpt.1989.53.
6
Active lucifer yellow secretion in renal proximal tubule: evidence for organic anion transport system crossover.肾近端小管中活性荧光素黄的分泌:有机阴离子转运系统交叉的证据。
J Pharmacol Exp Ther. 1999 May;289(2):1104-11.
7
Cimetidine and procainamide secretion by proximal tubules in vitro.西咪替丁和普鲁卡因胺在体外近端小管的分泌。
Am J Physiol. 1982 Jun;242(6):F672-80. doi: 10.1152/ajprenal.1982.242.6.F672.
8
Pharmacokinetics and the effect of probenecid on the renal excretion mechanism of diprophylline.丙磺舒对二羟丙茶碱肾脏排泄机制的影响及其药代动力学
J Pharm Sci. 1992 Oct;81(10):1024-7. doi: 10.1002/jps.2600811014.
9
Renal transport of drugs: specificity and molecular mechanisms.药物的肾脏转运:特异性与分子机制
Clin Exp Pharmacol Physiol. 1996 Oct-Nov;23(10-11):986-9. doi: 10.1111/j.1440-1681.1996.tb01155.x.
10
Interactions of organic anions with the organic cation transporter in renal BBMV.肾刷状缘膜小泡中有机阴离子与有机阳离子转运体的相互作用。
Am J Physiol. 1988 Jan;254(1 Pt 2):F56-61. doi: 10.1152/ajprenal.1988.254.1.F56.

引用本文的文献

1
Levofloxacin and ciprofloxacin decrease procainamide and N-acetylprocainamide renal clearances.左氧氟沙星和环丙沙星会降低普鲁卡因胺和N-乙酰普鲁卡因胺的肾脏清除率。
Antimicrob Agents Chemother. 2005 Apr;49(4):1649-51. doi: 10.1128/AAC.49.4.1649-1651.2005.
2
Principles of drug administration in renal insufficiency.肾功能不全时的给药原则
Clin Pharmacokinet. 1997 Jan;32(1):30-57. doi: 10.2165/00003088-199732010-00002.